Amgen appoints regulatory affairs and safety specialist

19-May-2014

Steven Galson gains a promotion

Amgen has appointed Steven Galson as SVP, Global Regulatory Affairs and Safety.

Galson joined Amgen as VP of Global Regulatory Affairs in October 2010 and has led Amgen\'s regulatory team for the past three and a half years, and he now takes on expanded responsibilities to communicate the safety profile of the company\'s medicines.

Galson joined Amgen from Science Applications International, where was SVP for Civilian Health Operations and Chief Health Scientist from October 2009 to October 2010.

Prior to that, Galson had a distinguished 23-year career in US Public Health Service. From 2007 to 2009, he was acting US Surgeon General. During the Bush-Obama transition in 2009, he was acting Assistant Secretary for Health. From 2001 to 2007, he was Deputy Director and Director of the FDA\'s Centre for Drug Evaluation and Research.

Sign up for your free email newsletter

Prior to this, Galson was Director of the Environmental Protection Agency\'s Office of Science Coordination and Policy, Office of Prevention, Pesticides and Toxic Substances. He has also served as Chief Medical Officer of the US Department of Energy. He began his Public Health Service career as an epidemiological investigator at the Centres for Disease Control after completing a residency in internal medicine at the hospitals of the Medical College of Pennsylvania.

Companies